Hematologic malignancies

K. Sandstrom, L. Tuason, C. Redovan, P. Rayman, R. Tubbs, D. Resta, P. Elson, and J. Finke, Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy hematological, immunological, and pharmacodynamic findings. Clin Cancer Res 2(2) 347-357 (1996). 

Due to autopsy results, the incidence of splenic abscesses is estimated to be between 0.2 and 0.7% (Paris 1994). Underlying disorders are infection, emboli, trauma, recent surgery, malignant hematologic conditions, and immunosuppression. In the past, antibiotic therapy and splenectomy were the only available treatments. While mortality rates of surgical drainage range between 13 and 28% (Lucey et al. 2002), several authors... 

Clear Cell Sarcoma of the Kidney 443 Rhahdoid Tumor of the Kidney 443 Juvenile Renal Cell Carcinoma 445 Renal Medullary Carcinoma 446 Malignant Hematologic Diseases 446 Peripheral Primitive Neuroectodermal Tumor 446 Metastases 447... 

Buchler, T., J. Michalek, L. Kovarova, R. Musilova, and R. Hajek. 2003. Dendritic cell-based immunotherapy for the treatment of hematological malignancies. Hematology 8(2) 97-104. 

Patients in the more aggressive categories are less likely to exhibit involvement of the skin and have a less favorable prognosis [10]. Those patients may have a definable hematological disorder such as a myelodysplastic syndrome, myeloproliferative disorder, acute leukemia, or a malignant lymphoma. In aggressive mastocytosis and mast cell leukemia, the clinical course is determined by the rapidity of the increase in mast cell numbers. 

Rare Neuroleptic malignant syndrome, hematologic abnormalities... 

Symptoms that are not a result of the direct effects of the tumor are termed paraneoplastic syndromes. They may be caused by substances secreted by the tumor or in response to the tumor and often occur in tissues far from the site of malignancy. Fhraneoplastic syndromes are numerous and affect a wide variety of systems, including the endocrine, neurologic, skeletal, renal, metabolic, vascular, and hematologic systems. 

The malignant lymphomas are hematologic cancers that consist of a cluster of diseases of the lymphoid tissue. The primary malignant cells for lymphomas are lymphocytes of B-cell, T-cell, and NK-cell origin. These cells originate from a small population of... 

O The acute leukemias are hematologic malignancies of bone marrow precursors characterized by excessive production of immature hematopoietic cells. This proliferation results in a large number of immature cells (blasts) appearing in the peripheral blood and bone marrow causing failure of normal hematopoiesis. 

O Hematopoietic cell transplantation (HCT) is a procedure used mainly to treat hematologic malignancies via high-dose chemotherapy and/or a graft-versus-tumor effect. 

Anonymous. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies An individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005 23 5074-5087. 

Lung cancer Breast cancer Melanoma Colorectal cancer Hematologic malignancies (i.e., leukemia)... 

Hematologic malignancies such as multiple myeloma and, rarely, lymphomas are other causes of hypercalcemia. 

Autologous hematopoietic stem cell (HSC) transplantation, a standard treatment for hematological malignancies, such as non-Hodgkin s... 

Hematologic Head and Neck Gynecologic Genitourinary Gastrointestinal Endocrine Carcinoma Breast Cancer Malignancies Cancer Cancer Cancer Cancer Cancer of Unknown... 

Hematologic Malignancies ChIVPP chlorambucil/ vinblastine/ procarbazine/ prednisone Chlorambucil 6 mg/M2 PO days 1-14 Vinblastine 6 mg/M2 IV days 1,8 -maximum dose is 10 mg Procarbazine 100 mg/M2 PO days 1-14 Prednisone 40 mg/M2 PO days 1-14... 

---